SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-14-004547
Filing Date
2014-08-05
Accepted
2014-08-05 16:50:00
Documents
2
Period of Report
2014-08-04

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1487
2 POWER OF ATTORNEY exhibit24-1.htm EX-24.EXHIBIT 24 3921
  Complete submission text file 0001062993-14-004547.txt   6740
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address
LINK MAX (Reporting) CIK: 0001050944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34236 | Film No.: 141016761